Lucid LCID 深 滬
已收盤 11-06 16:00:00 美东时间
3.29
+0.310
+10.40%
華盛通- 最 高3.29
- 今 開3.07
- 成交量 985.37万股
- 最 低 3.03
- 昨 收 2.98
- 總市值 12.96亿
- 52周最高 14.2599
- 市盈率 靜 --
- 換手率 2.50%
- 52周最低 2.37
- 委 比 -77.09%
- 總股本 3.94亿
- 歷史最高 577.50
- 量 比 0.69
- 振 幅 8.72%
- 歷史最低 2.37
- 每 手 1
- 風險率 3.34%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多QNTM收跌4.52%，成交额17.05万美元
11月6日，QNTM（QNTM）收跌4.52%，报2.11美元，成交额17.05万美元，市值1706.47万美元。 行情数据 • 开盘价：2.2美元 • 最高价...
11-06 08:53
Lucid 期权解盘 | 成交量5.5万张，3.5美元关口博弈激烈
<p>美东时间11月3日，Lucid涨0.67%，收盘报3.02美元；当日期权总成交量达5.5万张，环比前一日放大2.02倍，较90日均量增加1.20倍，其中看跌期权占比83%，看涨期权占比17%。</p><p>从全日成交量来看，Lucid当日最活跃的期权<a class="cms-content-native-jump-btn" data-type="20003" data-name="LCID_261106_C_3.5" data-code="LCID261106C35000" data-mark="special">LCID_261106_C_3.5</a>合约总计成交0.55万张，收盘价0.030美元。</p><p>期权链：</span><a class="cms-content-native-jump-btn" data-chain="true" data-type="20002" data-name="Lucid" data-code="LCID" data-mark="sp
11-04 08:05
Lucid Diagnostics Announces Publication of Landmark 12,000-Patient Real-World EsoGuard® Study
Largest peer-reviewed study of nonendoscopic esophageal precancer testing to date demonstrates the efficiency and scalability of EsoCheck® cell collection in under two minutes NEW YORK, Nov....
11-03 21:15
LCID收跌0.66%，成交额3962.36万美元
11月3日，LCID（LCID）收跌0.66%，报3美元，成交额3962.36万美元，市值11.82亿美元。 行情数据 • 开盘价：3.09美元 • 最高价：...
11-03 06:40
Rivian Stock Forecast: RIVN Bounces Off $11.37 After Q3 Beat, With $12.65 the First Test
TradingKey - Rivian stock forecast: RIVN jumps 6.20% off $11.37 support after a Q3 beat and raised delivery guide, but still trades below its 50-day and 100-day EMAs.
11-02 11:30
QNTM收涨2.16%，成交额24.73万美元
10月29日，QNTM（QNTM）收涨2.16%，报2.37美元，成交额24.73万美元，市值1916.74万美元。 行情数据 • 开盘价：2.42美元 • 最...
10-29 07:43
Longeveron Announces Engagement of Lucid Capital Markets
Longeveron Inc. has retained Lucid Capital Markets as its financial advisor to explore potential strategic opportunities, including a business combination. The company specializes in developing regenerative medicines, with its lead product laromestrocel (Lomecel-B®), an allogeneic mesenchymal stem cell therapy, receiving multiple FDA designations. Forward-looking statements are subject to risks and uncertainties that could impact future outcomes.
10-28 13:15
LCID收跌3.41%，成交额2430.43万美元
10月27日，LCID（LCID）收跌3.41%，报3.4美元，成交额2430.43万美元，市值13.4亿美元。 行情数据 • 开盘价：3.46美元 • 最高价...
10-27 05:37
Acumen Pharmaceuticals (ABOS) Q3 2026 Earnings Call: ALTITUDE-AD Readout Due in November
Acumen Pharmaceuticals’ Q3 2026 earnings call covered its $79 million cash balance and the November ALTITUDE-AD Phase II readout for sabirnetug.
10-26 20:00
Oxford Lane Capital Corp. Prices Preferred Stock Offering
Oxford Lane Capital Corp. has priced an additional 1,440,000 shares of its 8.25% Series 2031 Term Preferred Shares at $24.85 per share, raising $35,784,000 in gross proceeds. The underwriters have a 30-day option to purchase up to 216,000 additional shares. The Preferred Stock will be treated as a single series with the Existing Preferred Stock, with the same terms and CUSIP. Upon issuance, there will be 4,200,000 shares outstanding. The net proc...
10-22 12:00
